Michael Kerger

4.5k total citations
19 papers, 666 citations indexed

About

Michael Kerger is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Michael Kerger has authored 19 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Michael Kerger's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and HIV, Drug Use, Sexual Risk (4 papers). Michael Kerger is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and HIV, Drug Use, Sexual Risk (4 papers). Michael Kerger collaborates with scholars based in Australia, Canada and United Kingdom. Michael Kerger's co-authors include Campbell Aitken, Peter Higgs, David Moore, Anthony J. Costello, Nick Crofts, Helen Crowe, Justin S. Peters, Declan G. Murphy, Niall M. Corcoran and Christopher M. Hovens and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Infectious Diseases and European Urology.

In The Last Decade

Michael Kerger

19 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kerger Australia 10 324 217 143 85 82 19 666
Richard D. Burt United States 13 356 1.1× 28 0.1× 67 0.5× 167 2.0× 10 0.1× 18 597
Lise Mørkved Helsingen Norway 13 59 0.2× 154 0.7× 44 0.3× 57 0.7× 67 0.8× 29 804
Sung Hwi Hong South Korea 14 80 0.2× 125 0.6× 35 0.2× 25 0.3× 27 0.3× 27 582
Dori Klemanski United States 13 191 0.6× 123 0.6× 51 0.4× 143 1.7× 5 0.1× 23 807
John H. Rogers United States 12 62 0.2× 167 0.8× 19 0.1× 61 0.7× 30 0.4× 31 476
Neerav Monga Canada 14 157 0.5× 64 0.3× 11 0.1× 99 1.2× 48 0.6× 28 718
Samir Hidar Tunisia 16 53 0.2× 54 0.2× 21 0.1× 158 1.9× 31 0.4× 59 818
Laura Peters United States 9 45 0.1× 202 0.9× 22 0.2× 15 0.2× 68 0.8× 15 392
Jammbe Musoro Belgium 13 68 0.2× 155 0.7× 20 0.1× 56 0.7× 14 0.2× 27 533
Douglas Mogul United States 15 149 0.5× 107 0.5× 15 0.1× 85 1.0× 23 0.3× 52 673

Countries citing papers authored by Michael Kerger

Since Specialization
Citations

This map shows the geographic impact of Michael Kerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kerger more than expected).

Fields of papers citing papers by Michael Kerger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kerger. The network helps show where Michael Kerger may publish in the future.

Co-authorship network of co-authors of Michael Kerger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kerger. A scholar is included among the top collaborators of Michael Kerger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kerger. Michael Kerger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liow, Elizabeth, Chol-Hee Jung, Bernard J. Pope, et al.. (2022). Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy. Clinical Genitourinary Cancer. 20(5). 452–458. 9 indexed citations
2.
Mangiola, Stefano, Geoff Macintyre, Ryan Hutchinson, et al.. (2021). MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer. Prostate Cancer and Prostatic Diseases. 24(4). 1167–1180. 6 indexed citations
3.
Kerger, Michael, Christopher M. Hovens, Justin S. Peters, et al.. (2021). The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade. British Journal of Urology. 128(S3). 45–51. 7 indexed citations
4.
Lau, Edmund, Fairleigh Reeves, Ken Chow, et al.. (2020). Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression. Genome Medicine. 12(1). 72–72. 42 indexed citations
5.
Mangiola, Stefano, Ryan Stuchbery, Ken Chow, et al.. (2019). Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat. Endocrine Connections. 8(5). 547–558. 16 indexed citations
6.
Lo, Kevin, Michael Kerger, John Pedersen, et al.. (2017). 3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk prediction. Pathology - Research and Practice. 213(12). 1523–1529. 3 indexed citations
7.
Corcoran, Niall M., Christopher M. Hovens, Michael Kerger, et al.. (2015). The predictive value of ARv7 expression in localized prostate caner treated with abiraterone, degarelix, and bicalutamide.. Journal of Clinical Oncology. 33(7_suppl). 71–71. 5 indexed citations
8.
Hong, Matthew, Nikhil Sapre, Pramit M. Phal, et al.. (2013). Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology. Clinical & Experimental Metastasis. 31(2). 159–167. 5 indexed citations
9.
Kerger, Michael, Matthew Hong, John Pedersen, et al.. (2012). Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysis. Pathology. 44(3). 204–208. 8 indexed citations
10.
Connolly, Stephen S., Paul Cathcart, Michael Kerger, et al.. (2011). Robotic radical prostatectomy as the initial step in multimodal therapy for men with high‐risk localised prostate cancer: initial experience of 160 men. British Journal of Urology. 109(5). 752–759. 28 indexed citations
11.
Dundee, Philip, et al.. (2011). 631 ANDROSTENEDIONE IS THE MOST EFFICIENT PRECURSOR OF INTRAPROSTATIC TESTOSTERONE PRODUCTION IN PRIMARY HUMAN PROSTATE CANCER TISSUE. European Urology Supplements. 10(2). 204–205. 1 indexed citations
12.
Murphy, Declan G., Michael Kerger, Helen Crowe, Justin S. Peters, & Anthony J. Costello. (2009). Operative Details and Oncological and Functional Outcome of Robotic-Assisted Laparoscopic Radical Prostatectomy: 400 Cases with a Minimum of 12 Months Follow-up. European Urology. 55(6). 1358–1367. 144 indexed citations
13.
Murphy, Declan, et al.. (2008). Operative details and medium-term oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: our first 400 cases with a minimum of 1 year follow-up.. 8 indexed citations
14.
Aitken, Campbell, Rhonda McCaw, D. Scott Bowden, et al.. (2004). Molecular Epidemiology of Hepatitis C Virus in a Social Network of Injection Drug Users. The Journal of Infectious Diseases. 190(9). 1586–1595. 45 indexed citations
15.
Aitken, Campbell, et al.. (2002). The impact of a police crackdown on a street drug scene: evidence from the street. International Journal of Drug Policy. 13(3). 193–202. 228 indexed citations
16.
Aitken, Campbell, Michael Kerger, & Nick Crofts. (2002). Peer‐delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. Drug and Alcohol Review. 21(1). 33–37. 52 indexed citations
17.
Kerger, Michael, Campbell Aitken, Nick Crofts, & Macfarlane Burnet. (2001). Piloting peer-delivered hepatitis C testing and counselling based at a needle and syringe program.. 1 indexed citations
18.
Aitken, Campbell, Michael Kerger, & Nick Crofts. (2000). Drivers Who Use Illicit Drugs: behaviour and perceived risks. Drugs Education Prevention and Policy. 7(1). 39–50. 46 indexed citations
19.
Aitken, Campbell, Michael Kerger, & Nick Crofts. (2000). Drivers Who Use Illicit Drugs: behaviour and perceived risks. Drugs Education Prevention and Policy. 7(1). 39–50. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard D. Burt Breakdown of academic impact, for papers by Lise Mørkved Helsingen Breakdown of academic impact, for papers by Sung Hwi Hong Breakdown of academic impact, for papers by Dori Klemanski Breakdown of academic impact, for papers by John H. Rogers Breakdown of academic impact, for papers by Neerav Monga Breakdown of academic impact, for papers by Samir Hidar Breakdown of academic impact, for papers by Laura Peters Breakdown of academic impact, for papers by Jammbe Musoro Breakdown of academic impact, for papers by Douglas Mogul
Rankless by CCL
2026